Veerle Wijtvliet

7PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Quantum technologiesInnate immunityTransplantation immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 24, 2025
Brevibacterium casei: A Rare Cause of Peritoneal Dialysis-Associated Peritonitis.

Veerle Wijtvliet, Katrien Leyssens, Marleen Vanden Driessche

|Apr 03, 2023
Pseudo-acute kidney injury secondary to tepotinib.

Veerle Wijtvliet, Laurence Roosens, Charlotte De Bondt

|May 11, 2022
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

Arno Verleye, Veerle Wijtvliet, Steven Abrams

|Feb 15, 2022
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

Veerle Wijtvliet, Karl Martin Wissing, Daniel Abramowicz

|Dec 10, 2021
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Veerle P W M Wijtvliet, Kevin K Ariën, Steven Abrams

|Oct 04, 2021
SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern.

Veerle Wijtvliet, Kristien Ledeganck, Bart Peeters

Pageof 2